Skip to main content

Articles

Original Research
Group-Based Trajectory Models to Identify Sociodemographic and Clinical Predictors of Adherence Patterns to Statin Therapy Among Older Adults
Aisha Vadhariya, PhD Candidate; Marc L. Fleming, PhD, MPH, RPh; Michael L. Johnson, PhD; E. James Essien, MD, DrPH; Omar Serna, PharmD, BCACP; Tara Esse, PharmD, BCACP; Jeannie Choi, PharmD; Susan H. Boklage, MS, MPH; Susan M. Abughosh, PhD
Read More
Perspectives
Final Commencement Address
David B. Nash, MD, MBA
Read More
Original Research, Practice Management, Infectious Diseases
Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models
Thomas Lodise, PhD, PharmD; Kenneth LaPensee, PhD, MPH
Read More
Perspectives
Will We Ever Bend the Cost Curve in Healthcare?
Ehsan U. Syed, MD
Read More
FDA Approvals, In the News
Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer
Read More
Commencement 2019
Read More
FDA Approvals, In the News
First Chemoimmunotherapy Regimen Granted Accelerated Approval for Patients with Previously Treated DLBCL
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Effect of Fixed-Duration Venetoclax plus Obinutuzumab on Progression-Free Survival and Minimal Residual Disease Status in Treatment-Naïve Patients with CLL and Comorbidities
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Three-Year Follow-Up of Acalabrutinib and Obinutuzumab in Treatment-Naïve and Relapsed/Refractory CLL
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Comparison of 3 Rituximab-Containing Regimens as Primary Therapy in Patients with WM
Read More
Page 51 of 244
Results 501 - 510 of 2440